Scientists Engineer Precision Tool for Mitochondrial DNA Manipulation
A research team at Fujita Health University has developed a precision genome-editing approach to modulate levels of mutant mitochondrial DNA …
All Posts
Khondrion Secures €5M to Advance Small Molecule Therapy Toward Phase 3 Trial
Khondrion, a clinical-stage biotech company focused on primary mitochondrial disease (PMD), has secured up to €5M in Innovation Credit from …
Iktos Brings its Gen-AI Drug Design Platform to AWS Marketplace
Iktos, a company developing AI and robotic technologies for medicinal chemistry and small molecule drug design, has expanded its collaboration …
Crown Bioscience Shows 3D Bone Marrow Model to Improve Blood Cancer Drug Testing and Reduce Animal Use
At the 2025 Annual Meeting of the American Association for Cancer Research (AACR)—a major international conference focused on cancer science …
Moderna to Onboard R&D Teams to Benchling Platform for AI-Driven Research Integration
Benchling is expanding its collaboration with Moderna, which is now adopting the platform across its broader research organization. The rollout …
Startup Working with Italian Hospitals Raises €2.2M to Structure Medical Reports into Care Plans
Milan-based startup ReportAId has raised €2.2 million in pre-seed funding to develop its AI platform aimed at converting unstructured medical …
North Bristol NHS Trust Becomes Reference Site for FUJIFILM’s Digital Pathology Platform
North Bristol NHS Trust has been named the first European reference site for FUJIFILM Healthcare’s SYNAPSE Pathology system, marking a …
Inductive Bio Raises $25M to Scale AI Platform for Predicting Drug Behavior Before Synthesis
Inductive Bio has secured $25 million in Series A financing to expand its machine learning platform for small molecule drug …
Flagship Launches Etiome with $50M to Use AI for Stage-Specific Drug Target Discovery
Flagship Pioneering has launched Etiome, a biotechnology start-up focused on identifying and drugging biomarkers that correspond to specific stages of …
Twist Bioscience Spins Out Atlas Data Storage with $155M to Commercialize DNA-Based Data Storage
Twist Bioscience has launched Atlas Data Storage as an independent company focused entirely on the development and commercialization of DNA …
Lantern Pharma Advances AI-Guided Drug into Phase 1b/2 Trial for Triple Negative Breast Cancer
Lantern Pharma announced FDA clearance of its Investigational New Drug (IND) application for LP-184 in the treatment of triple negative …
Recursion Reports Positive Early Trial Results for Familial Adenomatous Polyposis
Recursion has released early results from its ongoing Phase 1b/2 TUPELO trial evaluating REC-4881, an investigational MEK1/2 inhibitor, as a …